Results 1 to 10 of about 802,860 (405)
Human Vaccines & Immunotherapeutics, 2021 Objectives: This study summarizes passive surveillance data for adverse events following immunization (AEFI) in Zhejiang province. Methods: The AEFI reports and number of doses on all vaccines used were extracted from the national AEFI surveillance ...
Xuejiao Pan +7 more
doaj +1 more source
Human Vaccines & Immunotherapeutics, 2021 Background: To evaluate the missed opportunities for vaccination (MOV) in Zhejiang province by using the global methodology from World Health Organization (WHO). Methods: Based on the WHO Planning Guide to Reduce Missed Opportunities for Vaccination (MOV)
Yaping Chen +4 more
doaj +1 more source
Vaccines and routine immunization strategies during the COVID-19 pandemic
Human Vaccines & Immunotherapeutics, 2020 Severe acute respiratory syndrome coronavirus 2 related disease (COVID-19) is now responsible for one of the most challenging and concerning pandemics.
E. Dinleyici +4 more
semanticscholar +1 more source
BMC Public Health, 2021 Background Inactivated Polio Vaccine (IPV) campaign was conducted in February 2019 in Karachi where needle-free injectors were introduced for the administration of the fractional dose of IPV (fIPV) on a large scale.
Umar Farooq Bullo +10 more
doaj +1 more source
BMC Public Health, 2022 Background The alcohol consumption pattern, alcoholic liver disease (ALD) prevalence and related risk factors among alcohol drinkers in Beijing haven’t been fully elucidated.
Huai Wang +6 more
doaj +1 more source
Human Vaccines & Immunotherapeutics, 2020 Disparities in HPV vaccination coverage by metropolitan statistical area (MSA) status were observed in the 2016 and 2017 National Immunization Survey – Teen (NIS-Teen).
Tanja Y. Walker +6 more
doaj +1 more source
Frontiers in Public Health, 2023 BackgroundConcern about the risk of peripheral facial palsy (PFP) following vaccination is one reason for hesitancy in influenza vaccination. However, the association between the flu vaccine and PFP is still controversial, and further evidence is ...
Tianchi Yang +9 more
doaj +1 more source
BMC Public Health, 2021 Background Infant immunization coverage worldwide has plateaued at about 85%. Using existing survey data to conduct analyses beyond estimating coverage may help immunization programmes better tailor strategies to reach un- and under-immunized children ...
Yue Huang, M. Carolina Danovaro-Holliday
doaj +1 more source
MMWR. Morbidity and mortality weekly report, 2019 Vaccination against human papillomavirus (HPV) is recommended to prevent new HPV infections and HPV-associated diseases, including some cancers. The Advisory Committee on Immunization Practices (ACIP)* routinely recommends HPV vaccination at age 11 or 12
E. Meites +5 more
semanticscholar +1 more source
JYNNEOS vaccine safety monitoring in the Republic of Korea, 2022: a cross-sectional study [PDF]
Osong Public Health and Research Perspectives, 2023 Objectives With the recent global mpox outbreak, the JYNNEOS vaccine (Modified Vaccinia Ankara-Bavarian Nordic) was developed as a third-generation smallpox vaccine and initially favored for mpox immunization.
Jaeeun Lee +5 more
doaj +1 more source